Q+A article

Dalmeet Singh Chawla

The chemist who uses paper devices to spot fake and substandard drugs

For years, chemist Marya Lieberman of the University of Notre Dame and her team have been developing analytical paper diagnostics that...

Dalmeet Singh Chawla

Q&A: Australia’s chief scientist proposes a centralized national plan for open access

Australia lags behind comparable research-intensive countries in Europe in the development of open-access policies, according to a recent...

Dalmeet Singh Chawla

How one US organization hopes to make retractions more visible

There’s ample evidence that retracted papers — 2,500 per year and growing — continue to attract citations that do not mention the fact...

Dalmeet Singh Chawla

Warning over coronavirus and predatory journals

With hundreds of questionable journals appearing and disappearing on a regular basis, researchers need to be vigilant in their approach...

Dalmeet Singh Chawla

Q&A: Physicist and record-breaking archer James Martin

Flight shooting, a form of archery, is an ancient sport with a simple objective: launching arrows as far as possible. The details are...

Dalmeet Singh Chawla

Why Drugs for Alzheimer’s Are So Hard to Develop

Finding treatments for Alzheimer’s disease is simultaneously one of the most pressing and difficult tasks in medicine today. Between 2000...

Dalmeet Singh Chawla

Can automated tools reliably rate research reproducibility?

Recently the United States Defense Advanced Research Projects Agency (DARPA) solicited research proposals on developing automated tools...

Dalmeet Singh Chawla